Oxaliplatin trials for Colorectal Cancer Metastatic

All Oxaliplatin trials · All Colorectal Cancer Metastatic trials

Phase breakdown

Recruiting trials studying Oxaliplatin for Colorectal Cancer Metastatic

• Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
  NCT06282445 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
  NCT05727163 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
  NCT05611034 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Oxaliplatin for Colorectal Cancer Metastatic?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.